BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22887854)

  • 1. Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-κB-mediated MMP-9 upregulation.
    Long H; Xie R; Xiang T; Zhao Z; Lin S; Liang Z; Chen Z; Zhu B
    Stem Cells; 2012 Oct; 30(10):2309-19. PubMed ID: 22887854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
    Tang S; Xiang T; Huang S; Zhou J; Wang Z; Xie R; Long H; Zhu B
    Cancer Lett; 2016 Jun; 376(1):137-47. PubMed ID: 27033454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.
    Long H; Xiang T; Qi W; Huang J; Chen J; He L; Liang Z; Guo B; Li Y; Xie R; Zhu B
    Oncotarget; 2015 Mar; 6(8):5846-59. PubMed ID: 25788271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
    Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
    J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
    Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
    Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.
    Xiang T; Long H; He L; Han X; Lin K; Liang Z; Zhuo W; Xie R; Zhu B
    Oncogene; 2015 Jan; 34(2):165-76. PubMed ID: 24362529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
    You Y; Li Y; Li M; Lei M; Wu M; Qu Y; Yuan Y; Chen T; Jiang H
    Clin Exp Immunol; 2018 Jan; 191(1):60-73. PubMed ID: 28868628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.
    Kato T; Fujita Y; Nakane K; Mizutani K; Terazawa R; Ehara H; Kanimoto Y; Kojima T; Nozawa Y; Deguchi T; Ito M
    Cytokine; 2013 Oct; 64(1):251-7. PubMed ID: 23876400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
    Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX
    Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression.
    Zhu F; Liu P; Li J; Zhang Y
    Oncol Rep; 2014 May; 31(5):2049-54. PubMed ID: 24604010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
    Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
    Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNAI1 overexpression induces stemness and promotes ovarian cancer cell invasion and metastasis.
    Lu ZY; Dong R; Li D; Li WB; Xu FQ; Geng Y; Zhang YS
    Oncol Rep; 2012 May; 27(5):1587-91. PubMed ID: 22344746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
    Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
    Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein inhibits MMP-2 expression in human ovarian cancer cells by suppressing the p38 MAPK-dependent NF-κB signaling pathway.
    Yan H; Xin S; Wang H; Ma J; Zhang H; Wei H
    Anticancer Drugs; 2015 Jul; 26(6):649-56. PubMed ID: 25811965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R; Wu Q; Liu F; Wang Y
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.